CTOs on the Move

Reckitt Benckiser

www.rb.com

 
We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We`re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world`s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.rb.com
  • 399 Interpace Parkway P.O. Box 225
    Parsippany, NJ USA 07054
  • Phone: 973.404.2600

Executives

Name Title Contact Details
Rama Donepudi
Chief Information Officer (CIO), Global Nutrition at Reckitt Profile
Filippo Catalano
Chief Information and Digitisation Officer Profile
Magdalena Skorupa
Director of Cyber Risk and Compliance Profile

Similar Companies

Ultracision

Ultracision, Inc. is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Channel 10 Klvx

Channel 10 Klvx is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.

Planet Organic Health

Planet Organic Health Corp. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmagistics

Pharmagistics, LLC is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.